Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Esophagogastric Junction (EGJ)”

12 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 12 of 12 results

Testing effectiveness (Phase 2)UnknownNCT04813523
What this trial is testing

Pembrolizumab Plus Neoadjuvant Chemotherapy for Locally Advanced EGJ Adenocarcinoma

Who this might be right for
Adenocarcinoma of Esophagogastric JunctionNeoadjuvant ChemotherapyPembrolizumab
Tianjin Medical University Cancer Institute and Hospital 30
Large-scale testing (Phase 3)Not Yet RecruitingNCT03961841
What this trial is testing

Perioperative Combination Chemotherapy Versus Chemoradiation for Locally Advanced EGJ Adenocarcinoma

Who this might be right for
Esophagogastric Junction DisorderNeoplasms
Sixth Affiliated Hospital, Sun Yat-sen University 900
Early research (Phase 1)Active Not RecruitingNCT04044859
What this trial is testing

ADP-A2M4CD8 as Monotherapy or in Combination With Either Nivolumab or Pembrolizumab in HLA-A2+ Subjects With MAGE-A4 Positive Tumors (SURPASS)

Who this might be right for
Endometrial CancerEsophageal CancerEsophagogastric Junction (EGJ)+6 more
USWM CT, LLC 120
Large-scale testing (Phase 3)Ended earlyNCT04675983
What this trial is testing

Sintilimab Plus Ramucirumab as First-line Treatment for G/EGJ Adenocarcinoma (ORIENT-106)

Who this might be right for
Gastric Adenocarcinoma
Innovent Biologics (Suzhou) Co. Ltd. 36
Testing effectiveness (Phase 2)Study completedNCT05259696
What this trial is testing

Glycan Mediated Immune Regulation With a Bi-Sialidase Fusion Protein (GLIMMER-01)

Who this might be right for
OncologyMelanomaOvarian Cancer+14 more
Palleon Pharmaceuticals, Inc. 69
Large-scale testing (Phase 3)Study completedNCT03081143
What this trial is testing

Ramucirumab Plus FOLFIRI Versus Ramucirumab Plus Paclitaxel in Patients With Advanced or Metastatic Gastric Cancer, Who Failed One Prior Line of Palliative Chemotherapy

Who this might be right for
Advanced Gastric or EGJ Cancer
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest 429
Testing effectiveness (Phase 2)UnknownNCT04061928
What this trial is testing

Toripalimab With Preoperative Chemoradiotherapy for LA-EGJ

Who this might be right for
PD-1ChemoradiotherapyGastroesophageal Junction Cancer
Peking University 45
Testing effectiveness (Phase 2)WithdrawnNCT05245760
What this trial is testing

ChemoRadiation And Tislelizumab for Esophageal/EGJ Cancer

Who this might be right for
Esophageal CancerEsophagogastric Junction Cancer
Zhonglin Hao
Large-scale testing (Phase 3)UnknownNCT02512380
What this trial is testing

Neoadjuvant SLOT Versus SOX in Patients With Locally Advanced, Resectable Gastric/Esophagogastric Junction (EGJ) Cancer

Who this might be right for
Gastric Adenocarcinoma
Chinese Academy of Medical Sciences 380
Not applicableStudy completedNCT06329583
What this trial is testing

Establishing Pressures at the EGJ During Diaphragmatic Breathing Using High-resolution Esophageal Manometry

Who this might be right for
Gastroesophageal RefluxDysphagiaEsophageal Motility Disorders
Mayo Clinic 13
Early research (Phase 1)Ended earlyNCT03253185
What this trial is testing

SC-007 in Subjects With Advanced Cancer

Who this might be right for
Colorectal Cancer (CRC)Gastric Cancer
AbbVie 7
Not applicableUnknownNCT01956877
What this trial is testing

Assessment of Normal Values of Esophagogastric Junction (EGJ) Distensibility in Healthy Volunteers

Maastricht University Medical Center 15